<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2305233689
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SOLFISAN 10 mg Film Coated Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SOLIFENACIN SUCCINATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        121
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AJA PHARMACEUTICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AJA PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1916]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AJA PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AJA PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G04BD08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">The active substance of Solfisan belongs to the group of anticholinergics. These medicines are used to reduce the activity of an overactive bladder. This enables you to wait longer before having to go to the bathroom and increases the amount of urine that can be held by your bladder.<br />Solfisan is used to treat the symptoms of a condition called overactive bladder. These symptoms include: having a strong, sudden urge to urinate without prior warning, having to urinate frequently or wetting yourself because you could not get to the bathroom in time</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>Do not take Solfisan:</strong><br />- if you have an inability to pass water or to empty your bladder completely (urinary retention)<br />- if you have a severe stomach or bowel condition (including toxic megacolon, a complication associated with ulcerative colitis)<br />- if you suffer from the muscle disease called myasthenia gravis, which can cause an extreme weakness of certain muscles<br />- if you suffer from increased pressure in the eyes, with gradual loss of eye sight (glaucoma)<br />- if you are allergic to solifenacin or any of the other ingredients of this medicine (listed in section 6)<br />- if you are undergoing kidney dialysis<br />- if you have severe liver disease<br />- if you suffer from severe kidney disease or moderate liver disease and at the same time are being treated with medicines that may decrease the removal of Solfisan from the body (for<br />example, ketoconazole). Your doctor or pharmacist will have informed you if this is the case.<br />Inform your doctor if you have or ever had any of the above mentioned conditions before treatment with Solfisan starts.</p><p style="text-align:justify"><strong>Warnings and precautions</strong><br />Talk to your doctor or pharmacist before taking Solfisan<br />- if you have trouble emptying your bladder (=bladder obstruction) or have difficulty in passing urine (e.g. a thin urine flow). Risk of accumulation of urine in the bladder (urinary retention) is much higher.<br />- if you have some obstruction of the digestive system (constipation).<br />- if you are at risk of your digestive system slowing down (stomach and bowel movements). Your doctor will have informed you if this is the case.<br />- if you suffer from severe kidney disease.<br />- if you have moderate liver disease.<br />- if you have a stomach tear (hiatus hernia) or heartburn.</p><p style="text-align:justify">- if you have a nervous disorder (autonomic neuropathy).</p><p style="text-align:justify"><strong>Children and adolescents</strong><br /><u>Solfisan is not to be used in children or adolescents under 18 years.</u><br />Inform your doctor if you have or ever had any of the above mentioned conditions before treatment with Solfisan starts.</p><p style="text-align:justify">Before starting Solfisan, your doctor will assess whether there are other causes for your need to pass urine frequently (for example heart failure (insufficient pumping power of the<br />heart) or kidney disease). If you have a urinary tract infection, your doctor will prescribe you an antibiotic (a treatment against particular bacterial infections).</p><p style="text-align:justify"><strong>Other medicines and Solfisan</strong><br />Please tell your doctor or pharmacist if you are taking, have recently taken or might take other medicines.<br />It is especially important to inform your doctor if you are taking:<br />-other anticholinergic medicines, effects and side effects of both medications can be enhanced.<br />-cholinergics as they can reduce the effect of Solfisan.<br />-medicines, like metoclopramide and cisapride, which make the digestive system work faster. Solfisan can reduce their effect.<br />- medicines, like ketoconazole, ritonavir, nelfinavir, intraconazole, verapamil and diltiazem, which decrease the rate at which Solfisan is broken down by the body<br />-medicines like rifampicin, phenytoin and carbamazepine, as they may increase the rate at which Solfisan is broken down by the body.<br />- medicines such as bisphosphonates, that can cause or exacerbate inflammation of the gullet (oesophagitis).</p><p style="text-align:justify"><strong>Solfisan with food and drink</strong><br />Solfisan can be taken with or without food, depending on your preference.</p><p style="text-align:justify"><strong>Pregnancy and breast-feeding</strong><br />You should not use Solfisan if you are pregnant unless clearly necessary.<br />Do not use Solfisan if you are breast-feeding as solifenacin may get into your breast milk. If you think you may be pregnant or are planning to have a baby, ask your doctor or<br />pharmacist for advice before taking this medicine.</p><p style="text-align:justify"><strong>Driving and using machines</strong><br />Solfisan may cause blurred vision and sometimes sleepiness or tiredness. If you suffer from any of these side effects, do not drive or operate machinery.</p><p style="text-align:justify"><strong>Solfisan contains lactose.</strong> If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>Instructions for proper use</strong><br />Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.<br />You should swallow the whole tablet with some liquid. It can be taken with or without food, according to your preference. Do not crush the tablets. The usual dose is 5 mg per day, unless your doctor told you to take 10 mg per day. The 10 mg tablet can be divided into equal doses.</p><p style="text-align:justify"><strong>If you take more Solfisan than you should</strong><br />If you have taken too much Solfisan or if a child has accidentally taken Solfisan, contact your doctor or pharmacist immediately.<br />Symptoms of overdose may include: headache, dry mouth, dizziness, drowsiness and blurred vision, perceiving things that are not there (hallucinations), over-excitability, seizures (convulsions), difficulty breathing, elevated heart rate (tachycardia), accumu-lation of urine in the bladder (urinary retention) and dilated pupils (mydriasis)</p><p style="text-align:justify"><strong>If you forget to take Solfisan</strong><br />If you forget to take a dose at the usual time, take it as soon as you remember, unless itistime to take your next dose. Never take more than one dose per day. If you are in doubt, always consult your doctor or pharmacist.</p><p style="text-align:justify"><strong>If you stop taking Solfisan</strong><br />If you stop taking Solfisan, your symptoms of overactive bladder may return or worsen. Always consult your doctor, if you are considering stopping the treatment. If you have any further questions on the use of this product, ask your doctor or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />If you experience an allergic attack, or a severe skin reaction (e.g. blistering and peeling of the skin), you must inform your doctor or pharmacist immediately<br />Angioedema (skin allergy that results in the swelling that occurs in the tissue just below the surface of the skin) with airway obstruction (difficulty in breathing) has been reported in some patients on solifenacin. If angioedema occurs, Solfisan should be discontinued immediately and appropriate therapy and/or measures should be taken.</p><p style="text-align:justify"><strong>Solfisan may cause the following other side effects:</strong><br /><u>Very common (may affect more than 1 in 10 people)</u> - dry mouth</p><p style="text-align:justify"><u>Common (may affect up to 1 in 10 people)</u></p><p style="text-align:justify">-blurred vision<br />-constipation, nausea, indigestion with symptoms such as an abdominal fullness, abdominal pain, burping, nausea, and heartburn (dyspepsia), stomach discomfort</p><p style="text-align:justify"><u>Uncommon (may affect up to 1 in 100 people)</u></p><p style="text-align:justify">- urinary tract infection, bladder infection<br />- sleepiness, impaired sense of taste (dysgeusia)<br />- dry (irritated) eyes<br />- dry nasal passages<br />- reflux disease (gastro-oesophageal reflux), dry throat<br />- dry skin<br />- difficulty in passing urine<br />- tiredness, accumulation of fluid in the lower legs (oedema)</p><p style="text-align:justify"><u>Rare (may affect up to 1 in 1,000 people)</u></p><p style="text-align:justify">- lodging of a large amount of hardened stool in the large intestine (faecal impac tion)<br />- build up of urine in the bladder due to inability to empty the bladder (urinary retention)<br />- dizziness, headache<br />- vomiting<br />-itching, rash</p><p style="text-align:justify"><u>Very rare (may affect up to 1 in 10,000 people)</u></p><p style="text-align:justify">- hallucinations, confusion<br />- allergic rash</p><p style="text-align:justify"><u>Not known (frequency cannot be estimated from the available data)</u></p><p style="text-align:justify">- decreased appetite, high levels of blood potassium which can cause abnormal heart rhythm<br />- increased pressure in the eyes<br />- changes in the electrical activity of the heart (ECG), irregular heartbeat, feeling your heartbeat, faster heartbeat (Torsade de Pointes)<br />- voice disorder<br />- liver disorder<br />- muscle weakness - renal disorder</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Keep this medicine out of the sight and reach of children.</p><p style="text-align:justify">Do not use Solfisan after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.</p><p style="text-align:justify">Store below 30<sup>o</sup>C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Solfisan contains</p><p>&nbsp;The active substance is solifenacin succinate.<br />Solfisan 5 mg: Each Solfisan film-coated tablet contains 5 mg solifen&not;acin succinate equivalent to 3.8 mg solifenacin.<br />Solfisan 10 mg: Each Solfisan film-coated tablet contains 10 mg solifenacin succinate equivalent to 7.5 mg solifenacin.</p><p>The other ingredients are:<br />Lactose monohydrate<br />Maize starch<br />(Maize) starch, (partially) pregelatinised<br />Magnesium stearate<br />Water, purified</p><p>Coating<br />5 mg:<br />Hypromellose 5cp<br />Titanium dioxide (E171)<br />Macrogol 8000<br />Talc<br />Iron oxide yellow (E172)<br />Water, purified</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Solfisan 5 mg: light yellow, round, biconvex film coated tablets with a diameter of 5.8 mm
Solfisan 10 mg: light pink, round, biconvex film coated tablets with score line on one side nd plain on the other and with a diameter of 7.9 mm. The tablet can be divided into equal halves.
Solfisan tablets are supplied in blister packs of 30 tablets
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AJA Pharmaceutical Industries Company, Ltd.<br />Hail Industrial City MODON, Street No 32<br />PO Box 6979, Hail 55414<br />Kingdom of Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 05/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="text-align:justify">المادة الفعالة في سولفيسان تنتمي إلى مجموعة مضادات التحفيز بالكولين. وهذه الأدوية تستعمل لتخفيف نشاط المثانة ذات النشاط الزائد، وهذا يمكن المصاب من الإنتظار فترة أطول قبل ان يضطر للذها للحمام للتبول ويزيد من كمية البول التي يمكن ان تبقى محتجزة في المثانة.</p><p dir="RTL" style="text-align:justify">يتم إعطاء سولفيسان لعلاج الأعراض المرتبطة بالمثانة ذات النشاط الزائد وتشمل هذه الأعراض ما يلي:</p><p dir="RTL" style="text-align:justify">الشعور المفاجئ القوي والملح بالرغبة في التبول دون انذار سابق، زيادة وتيرة (معدل تكرار) التبول او نزول البول في الملابس بسبب عدم التمكن من الوصول للحمام في الوقت المناسب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify"><strong>لا تتناول سولفيسان في الحالات التالية:</strong></p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من عدم القدرة على التبول او عدم القدرة على تفريغ المثانة بالكامل عند التبول (احتباس البول).</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني من حالة شديدة في المعدة أو الأمعاء (بما فيها التسمم الكبير في القولون وهو احد المضاعفات المرتبطة بالتهاب القولون التقرحي).</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في العضلات يعرف بالوهن العضلي الذي يسبب ضعفا شديدا في عضلات معينة.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ارتفاع الضغط في العينين مع فقدان تدريجي للنظر(الجلوكاما).</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الحساسية للسوليفيناسين أو أي من مكونات هذا المنتج (المذكورة في الفقرة رقم-6)</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تخضع لجلسات الديلزة (غسيل الدم)</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني من مرض شديد بالكبد.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض شديد في الكلى او مرض متوسط الشدة في الكبد وتعالج في نفس الوقت بأدوية يمكن ان تخفض إفراز سولفيسان من الجسم (على سبيل المثال كيتوكونازول). وسيخبرك الطبيب أو الصيدلي اذا كانت تلك هي حالتك.</p><p dir="RTL" style="text-align:justify">قبل البدء في تناول علاج سولفيسان ينبغي عليك ابلاغ الطبيب اذا كنت مصابا او سبق ان اصبت بأي من الحالات المذكورة أعلاه.</p><p style="text-align:justify"><strong>تحذيرات واحتياطات</strong>:</p><p dir="RTL" style="text-align:justify">يجب عليك استشارة الطبيب أو الصيدلي قبل البدء في استعمال سولفيسان في الحالات التالية:</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في تفريغ المثانة (انسداد في المثانة) او صعوبة في التبول او ما يسمى عسر البول (تدفق بطيء وخفيف)، أو إذا كانت هناك خطورة عالية لتجمع البول في المثانة (احتباس البول).</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من إعاقة أو انسداد في القناة الهضمية (مثل الإمساك الشديد).</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت عرضة لحدوث بطء في نشاط جهازك الهضمي (حركة المعدة والأمعاء). وسيخبرك الطبيب أو الصيدلي اذا كانت تلك هي حالتك.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض شديد في الكلى.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض متوسط الشدة في الكبد.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من تمزق في المعدة (فتق سري) او حرقان بسبب الحموضة.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض أو خلل في الجهاز العصبي (اعتلال عصبي ذاتي)</p><p dir="RTL" style="text-align:justify"><strong>الأطفال والمراهقون</strong>:</p><p dir="RTL" style="text-align:justify">يجب عدم إعطاء سولفيسان للأطفال والمراهقين الذين تقل أعمارهم عن 18 عاماً.</p><p dir="RTL" style="text-align:justify">قبل البدء في تناول علاج سولفيسان ينبغي عليك ابلاغ الطبيب اذا كنت مصابا او سبق ان اصبت بأي من الحالات المذكورة أعلاه.</p><p dir="RTL" style="text-align:justify">وقبل البدء باستعمال سولفيسان سيقوم طبيبك بتقييم حالتك وخاصة لمعرفة ما إذا كنت تعاني من أي حالات أو أسباب أخرى تستدعي الحاجة إلى زيادة إدرار البول (على سبيل المثال فشل القلب اي نقص في قدرة القلب على ضخ الدم أو مرض الكلى).</p><p dir="RTL" style="text-align:justify">وإذا كنت تعاني من إصابة (عدوى) في المسالك البولية فسوف يصف لك الطبيب النوع المناسب من المضادات الحيوية (وهو علاج لقتل البكتيريا المسببة للعدوى)&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p><p dir="RTL" style="text-align:justify"><strong>الأدوية الأخرى و سولفيسان:</strong></p><p dir="RTL" style="text-align:justify">يرجى استشارة الطبيب أو الصيدلي إذا كنت تستعمل او استعملت حديثا او يتوقع ان تستخدم أي أدوية أخرى.</p><p dir="RTL" style="text-align:justify">ومن المهم بصورة خاصة ان تبلغ الطبيب اذا كنت تستخدم اي واحد أو أكثر من الأدوية التالية:</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اي دواء آخر من المجموعة المضادة للتحفيز بالكولين حيث أن الآثار الجانبية للدوائين يمن ان تزداد عند استعمالهما معاً.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اي دواء آخر من المجموعة المحفزة بالكولين حيث أنها تخفض مفعول سولفيسان.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض انواع الأدوية مثل كيتوكونازول، و ريتينافير، و نلفينافير، و انتراكونازول، و فيراباميل، و دلتيازيم التي تخفض سرعة تحلل سولفيسان في الجسم.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض انواع الأدوية مثل ريفامبيسين، و فينيتوين، و كارباميزابين التي تزيد من سرعة تحلل سولفيسان في الجسم.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض انواع الأدوية مثل بيزفوسفانات التي يمكن ان تسبب التهابات المريء أو تزيد من شدتها سولفيسان في الجسم.</p><p dir="RTL" style="text-align:justify"><strong>سولفيسان مع الأطعمة والمشروبات:</strong></p><p dir="RTL" style="text-align:justify">يمكن تناول سولفيسان مع الطعام او بدونه حسب رغبتك</p><p dir="RTL" style="text-align:justify"><strong>الحمل والإرضاع: </strong></p><p dir="RTL" style="text-align:justify">يجب عدم إعطاء سولفيسان لنساء حوامل أو يشتبه أنهن حوامل إلا في حالات الضرورة القصوى.</p><p dir="RTL" style="text-align:justify">يجب تفادي إعطاء سولفيسان للنساء المرضعات حيث أن السوليفيناسين يمكن ان يفرز في حليب الثدي.</p><p dir="RTL" style="text-align:justify">وإذا كانت المرأة تظن أنها حامل أو تنوي الحمل فيجب عليها استشارة الطبيب أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL" style="text-align:justify">&nbsp;المرضعات التوقف عن إرضاع الطفل عند استعماله (أثبتت التجارب على الحيوانات (الجرذان) أن المنتج يفرز في حليب الثدي).</p><p dir="RTL" style="text-align:justify"><strong>قيادة المركبات وتشغيل الآليات: </strong></p><p dir="RTL" style="text-align:justify">سولفيسان يمكن ان يسبب ضبابية او تشوش في النظر واحيانا يسبب النعاس أو التعب. فإذا شعرت انك تعاني من احد تلك الأعراض فيجب عليك عدم قيادة اي مركبات او تشغيل أي آليات.</p><p dir="RTL" style="text-align:justify"><strong>سولفيسان</strong> <strong>يحتوي على اللاكتوز</strong>:</p><p dir="RTL" style="text-align:justify">إذا كان طبيبك قد ابلغك بأن لديك عدم تقبل لبعض أنواع السكريات فيجب عليك الإتصال بالطبيب قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify"><strong>ارشادات الإستعمال السليم:</strong></p><p dir="RTL" style="text-align:justify">يجب عليك دائما استعمال هذا الدواء حسب تعليمات الطبيب تماما. وإذا كنت غير متأكد فيب عليك الإتصال بالطبيب أو الصيدلي.</p><p dir="RTL" style="text-align:justify">ويجب ان تبتلع القرص كاملا مع قليل من الماء او اي نوع آخر من السوائل. ويمكن تناوله مع الطعام أو بدون طعام حسب رغبتك. ويجب أن لا تمضغ القرص.</p><p dir="RTL" style="text-align:justify">الجرعة المعتادة هي 5 ملغم في اليوم إلا إذا ارشدك الطبيب بان تأخذ 10ملغم في اليوم.</p><p dir="RTL" style="text-align:justify">ويمكن تقسيم جرعة الـ10 ملغم إلى جرعتين متساويتين.</p><p dir="RTL" style="text-align:justify"><strong>إذا تناولت جرعة زائدة من سولفيسان</strong>:</p><p dir="RTL" style="text-align:justify">إذا تناولت جرعة زائدة من سولفيسان أو إذا تناوله طفل بالخطأ فيجب عليك الإتصال بالطبيب أو الصيدلي فورا .</p><p dir="RTL" style="text-align:justify">اعراض زيادة الجرعة تشمل الصداع وجفاف الفم والدوار وضبابية الرؤيا وتخيل اشياء غير حقيقية او غير موجودة (الهلوسة) والإنفعال الزائد، والتشنجات (التقلصات العضلية)، وصعوبة التنفس، وتسارع النبض (الخفقان)، وتجمع البول في المثانة (احتباس البول) وتوسع حدقة العينين (توسع البؤبؤ).</p><p dir="RTL" style="text-align:justify"><strong>إذا نسيت أن تتناول سولفيسان</strong>:</p><p dir="RTL" style="text-align:justify">إذا نسيت ان تتناول الجرعة المعتادة في وقتها فيجب عليك ان تأخذ تلك الجرعة حالما تتذكرها إلا إذا كان قد حل وقت تناول الجرعة التالية وفي هذه الحالة خذ الجرعة التالية التي حل موعدها وواصل الاستعمال كالمعتاد. ويجب ان لا تأخذ أبداً أكثر من جرعة واحدة في اليوم. وإذا كنت غير متأكد فيجب عليك استشارة الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:justify">هذا الدواء كغيره من الأدوية يمكن أن يسبب بعض الآثار الجانبية مع انها لا تحدث لدى جميع الأشخاص.</p><p style="text-align:justify">إذا حدثت لديك نوبة حساسية أو ردة فعل شديدة بالجلد (مثل ظهور نفط تحت الجلد او تقشر الجلد) من جراء تناول هذا الدواء فيجب عليك إبلاغ الطبيب أو الصيدلي فوراً.</p><p style="text-align:justify">تم الإبلاغ عن حالات من الوذمة الوعائية (حساسية جلدية تسبب التورم تحت سطح الجلد مباشرة) المصحوبة بانسدادات في مجرى التنفس (صعوبة التنفس) لدى بعض المرضى الذين كانوا يستخدمون سوليفيناسين. فإذا حدثت الوذمة الوعائية فيجب وقف استعمال سولفيسان فوراً وبدء العلاج أو الإجراءات العلاجية المناسبة.&nbsp; &nbsp;&nbsp;&nbsp;</p><p style="text-align:justify">ويمكن ان يسبب سولفيسان الآثار الجانبية التالية:</p><p style="text-align:justify"><u>تأثيرات شائعة جداً (يمكن ان تصيب ما يزيد عن&nbsp; 1 من بين كل 10 اشخاص):</u></p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم.</p><p style="text-align:justify"><u>تأثيرات شائعة (يمكن ان تصيب لغاية&nbsp; 1 من بين كل 10 اشخاص):</u></p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضبابية في الرؤيا</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إمساك، غثيان، عسر الهضم مع اعراض مثل الشعور بامتلاء البطن، وألم في البطن، والتكرع، والغثيان، والحرقة في المعدة، وعدم ارتياح أو مضايقة بالمعدة.</p><p style="text-align:justify"><u>تأثيرات غير شائعة (يمكن ان تصيب لغاية&nbsp; 1 من بين كل 100 شخص):</u></p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب (عدوى) بالمسالك البولية أو بالمثانة</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نعاس ، خلل او تعطل حاسة التذوق.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف(تهيج) العينين.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف فتحتي الأنف.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتداد بالمريء(ارتداد محتويات المعدة إلى المريء)، جفاف الحلق.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الجلد.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التبول.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعب، تجمع السوائل في أسفل الساقين وفي القدمين (تورم أوديمي).</p><p style="text-align:justify"><u>تأثيرات نادرة (يمكن ان تصيب لغاية&nbsp; 1 من بين كل 1000 شخص):</u></p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجمع كميات كبيرة من البراز الصلب في الأمعاء الغليظة (امتلاء كامل بالبراز)</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجمع كمية كبيرة من البول في المثانة نتيجة عدم القدرة على التبول (احتباس البول)</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار، صداع.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقيؤ.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة، طفح جلدي.</p><p style="text-align:justify"><u>تأثيرات نادرة جداً (يمكن ان تصيب لغاية&nbsp; 1 من بين كل 10000 شخص):</u></p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هلوسة وتشوش</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي ناتج عن الحساسية</p><p style="text-align:justify"><u>تأثيرات غير معروفة (لا يمكن تقدير معدلات الإصابة مخ خلال المعلومات المتوفرة):</u></p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية، ارتفاع مستوى البوتاسيوم في الدم مما قد يسبب اضطراب في انتظام نبض القلب.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الضغط داخل العينين</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في النشاط الكهربائي للقلب (تخطيط القلب)، عدم انتظام النبض، الإحساس بنبض القلب، تسارع النبض.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في الصوت.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في الكبد.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف في العضلات.</p><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في الكلى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">احفظ هذا الدواء بعيدا عن مرأى ومتناول الأطفال وفي درجة حرارة لاتزيد عن 30 درجة مئوية.</p><p dir="RTL" style="text-align:justify">لا تستعمل سولفيسان بعد تاريخ انتهاء صلاحيته المطبوع على العلبة وهو يشير إلى آخر يوم في ذلك الشهر.</p><p dir="RTL" style="text-align:justify">هذا المنتج الدوائي لا يحتاج إلى شروط خاصة للتخزين.</p><p dir="RTL" style="text-align:justify">إذا حدث تغير في لون هذا الدواء او ظهرت عليه اي من علامات التلف فيجب ان تستشير الصيدلي.</p><p dir="RTL" style="text-align:justify">لا تلقي بأي دواء في مياه الصرف الصحي او في النفايات المنزلية. وعليك ان تسأل الصيدلي عن كيفية التخلص من الأدوية التي لا تحتاجها. وهذه التدابير تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي &quot;سكسينات السوليفيناسين&quot;</p><p dir="RTL" style="text-align:justify">سولفيسان 5 ملغم : كل قرص من سولفيسان المغلف يحتوي على 5 ملغم من &quot;سكسينات السوليفيناسين&quot; اي ما يعادل 3,8 ملغم من السوليفيناسين.</p><p dir="RTL" style="text-align:justify">سولفيسان 10 ملغم: كل قرص من سولفيسان المغلف يحتوي على 10ملغم من &quot;سكسينات السوليفيناسين&quot; اي ما يعادل 7,5 ملغم من السوليفيناسين.</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي:</p><p dir="RTL" style="text-align:justify"><u>مادة الأساس في القرص:</u></p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لاكتوز مونو هيدرات</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نشا الذرة البيضاء</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نشا الذرة البيضاء المجلتن جزئيا ومسبقاً</p><p dir="RTL" style="text-align:justify"><u>غلاف القرص:</u></p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>قرص 5ملغم :</u></p><p dir="RTL" style="text-align:justify">&nbsp; &nbsp; &nbsp; &nbsp; هيبروميلوز 5سي بي</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثاني اكسيد التيتانيوم (إي 171)</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ماكروجول 8000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL" style="text-align:justify">&nbsp; &nbsp; &nbsp; &nbsp; تالك</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اكسيد الحديد الأصفر (إي 172)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ماء منقى</p><p dir="RTL" style="text-align:justify">&nbsp; &nbsp; &nbsp; &nbsp;<u>قرص 10ملغم :</u></p><p dir="RTL" style="text-align:justify">&nbsp; &nbsp; &nbsp; &nbsp; هيبروميلوز 5سي بي</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثاني اكسيد التيتانيوم (إي 171)</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ماكروجول 8000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL" style="text-align:justify">&nbsp; &nbsp; &nbsp; &nbsp; تالك</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اكسيد الحديد الأحمر (إي 172)</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اكسيد الحديد الأصفر (إي 172)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL" style="text-align:justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ماء منقى</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p style="text-align:justify">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">سولفيسان 5 ملغم : هي أقراص دائرية لونها أصفر فاتح محدبة الوجهين ومغلفة ويبلغ قطرها 5,8ملم</p><p dir="RTL" style="text-align:justify">سولفيسان 10 ملغم : هي أقراص دائرية لونها وردي فاتح محدبة الوجهين ومغلفة وعليها خط محفور على أحد الوجهين يقسمها إلى نصفين متساويتين والوجه الآخر بدون خط. ويبلغ قطرها 7,9ملم</p><p dir="RTL" style="text-align:justify">أقراص سولفيسان تقدم في عبوة تحتوي على&nbsp; 30 قرص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة آجا للصناعات الدوائية المحدودة</p><p>المدينة الصناعية مدن بحائل، شارع رقم 32</p><p>ص.ب. 6979، حائل 55414</p><p>المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ 05/2018م
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solfisan 5 mg film-coated tablets
Solfisan 10 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solfisan 5 mg: Each tablet contains 5 mg solifenacin succinate, equivalent to 3.8 mg
solifenacin
Solfisan 10 mg film-coated tablet: Each tablet contains 10 mg solifenacin succinate,
equivalent to 7.5 mg solifenacin
Excipient(s) with known effect:
Each 5 mg tablet contains 54.25 mg of lactose monohydrate
Each 10 mg tablet contains 108.5 mg of lactose monohydrate
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets
Solfisan 5 mg: light yellow, round, biconvex film coated tablets with a diameter of 5.8
mm
Solfisan 10 mg: light pink, round, biconvex film coated tablets with score line on one
side and plain on the other and with a diameter of 7.9 mm. The tablet can be divided
into equal doses.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Posology</u><br /><em>Adults, including the elderly</em><br />The recommended dose is 5 mg solifenacin succinate once daily. If needed, the dose may be increased to 10 mg solifenacin succinate once daily.</p><p style="text-align:justify"><em>Paediatric population</em><br />The safety and efficacy of Solfisan in children have not yet been established. Therefore, Solfisan should not be used in children.</p><p style="text-align:justify"><em>Patients with renal impairment</em><br />No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance &gt; 30 ml/min). Patients with severe renal impairment (creatinine clearance &le; 30 ml/min) should be treated with caution and receive no more than 5 mg once daily (see Section 5.2).</p><p style="text-align:justify"><em>Patients with hepatic impairment</em><br />No dose adjustment is necessary for patients with mild hepatic impairment. Patients with moderate hepatic impairment (Child-Pugh score of 7 to 9) should be treated with caution and receive no more than 5 mg once daily (see Section 5.2).</p><p style="text-align:justify"><em>Potent inhibitors of cytochrome P450 3A4</em><br />The maximum dose of Solfisan should be limited to 5 mg when treated simultaneously with ketoconazole or therapeutic doses of other potent CYP3A4- inhibitors e.g. ritonavir, nelfinavir, itraconazole (see Section 4.5).</p><p style="text-align:justify"><u>Method of administration</u><br />Solfisan should be taken orally and should be swallowed whole with liquids. It can be taken with or without food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solifenacin is contraindicated in
- patients with urinary retention, severe gastrointestinal condition (including toxic megacolon), myasthenia gravis or narrow-angle glaucoma and in patients at risk
for these conditions;
- patients hypersensitive to the active substance or to any of the excipients listed in 6.1;
- patients undergoing haemodialysis (see Section 5.2);
- patients with severe hepatic impairment (see Section 5.2);
- patients with severe renal impairment or moderate hepatic impairment and who are on treatment with a potent CYP3A4 inhibitor, e.g. ketoconazole (see Section 4.5).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Other causes of frequent urination (heart failure or renal disease) should be assessed before treatment with Solfisan. If urinary tract infection is present, an appropriate antibacterial therapy should be started.</p><p style="text-align:justify">Solfisan should be used with caution in patients with:</p><ul><li style="text-align:justify">clinically significant bladder outflow obstruction at risk of urinary retention.</li><li style="text-align:justify">gastrointestinal obstructive disorders.</li><li style="text-align:justify">risk of decreased gastrointestinal motility.</li><li style="text-align:justify">severe renal impairment (creatinine clearance &le; 30 ml/min; see Section 4.2 and 5.2), and doses should not exceed 5 mg for these patients.</li><li style="text-align:justify">moderate hepatic impairment (Child-Pugh score of 7 to 9; see Section 4.2 and 5.2), and doses should not exceed 5 mg for these patients.</li><li style="text-align:justify">concomitant use of a potent CYP3A4 inhibitor, e.g. ketoconazole (see 4.2 and 4.5).</li><li style="text-align:justify">&nbsp;hiatus hernia/gastro-oesophagal reflux and/or who are concurrently taking medicinal products (such as bisphosphonates) that can cause or exacerbate oesophagitis.</li><li style="text-align:justify">autonomic neuropathy.</li></ul><p style="text-align:justify">QT prolongation and Torsade de Pointes have been observed in patients with risk factors, such as pre-existing long QT syndrome and hypokalaemia.</p><p style="text-align:justify">Safety and efficacy have not yet been established in patients with a neurogenic cause for detrusor overactivity.</p><p style="text-align:justify">Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.</p><p style="text-align:justify">Angioedema with airway obstruction has been reported in some patients on solifenacin succinate. If angioedema occurs, solifenacin succinate should be discontinued and appropriate therapy and/or measures should be taken.</p><p style="text-align:justify">Anaphylactic reaction has been reported in some patients treated with solifenacin succinate. In patients who develop anaphylactic reactions, solifenacin succinate should be discontinued and appropriate therapy and/or measures should be taken. The maximum effect of Solfisan can be determined after 4 weeks at the earliest.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Pharmacological interactions</u><br />Concomitant medication with other medicinal products with anticholinergic properties may result in more pronounced therapeutic effects and undesirable effects.</p><p style="text-align:justify">An interval of approximately one week should be allowed after stopping treatment with Solfisan, before commencing other anticholinergic therapy. The therapeutic effect of solifenacin may be reduced by concomitant administration of cholinergic receptor agonists.</p><p style="text-align:justify">Solifenacin can reduce the effect of medicinal products that stimulate the motility of the gastro-intestinal tract, such as metoclopramide and cisapride.</p><p style="text-align:justify"><u>Pharmacokinetic interactions</u><br />In vitro studies have demonstrated that at therapeutic concentrations, solifenacin does not inhibit CYP1A1/2, 2C9, 2C19, 2D6, or 3A4 derived from human liver microsomes. Therefore, solifenacin is unlikely to alter the clearance of drugs metabolised by these CYP enzymes.</p><p style="text-align:justify"><u>Effect of other medicinal products on the pharmacokinetics of solifenacin</u></p><p style="text-align:justify">Solifenacin is metabolised by CYP3A4. Simultaneous administration of ketoconazole (200 mg/day), a potent CYP3A4 inhibitor, resulted in a two-fold increase of the AUC of solifenacin, while ketoconazole at a dose of 400 mg/day resulted in a three-fold increase of the AUC of solifenacin. Therefore, the maximum dose of Solfisan should be restricted to 5 mg, when used simultaneously with ketoconazole or therapeutic doses of other potent CYP3A4 inhibitors (e.g. ritonavir, nelfinavir, itraconazole) (see Section 4.2).</p><p style="text-align:justify">Simultaneous treatment of solifenacin and a potent CYP3A4 inhibitor is contraindicated in patients with severe renal impairment or moderate hepatic impairment.</p><p style="text-align:justify">The effects of enzyme induction on the pharmacokinetics of solifenacin and its metabolites have not been studied as well as the effect of higher affinity CYP3A4 substrates on solifenacin exposure. Since solifenacin is metabolised by CYP3A4, pharmacokinetic interactions are possible with other CYP3A4 substrates with higher affinity (e.g. verapamil, diltiazem) and CYP3A4 inducers (e.g. rifampicin, phenytoin, carbamazepin).</p><p style="text-align:justify"><u>Effect of solifenacin on the pharmacokinetics of other medicinal products</u></p><p style="text-align:justify"><em>Oral Contraceptives</em><br />Intake of Solfisan showed no pharmacokinetic interaction of solifenacin on combined oral contraceptives (ethinylestradiol/levonorgestrel).</p><p style="text-align:justify"><em>Warfarin</em><br />Intake of Solfisan did not alter the pharmacokinetics of R-warfarin or Swarfarin or their effect on prothrombin time.</p><p style="text-align:justify"><em>Digoxin</em><br />Intake of Solfisan showed no effect on the pharmacokinetics of digoxin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u><em>Fertility</em></u><br />Animal studies do not indicate direct harmful effects on fertility (see Section 5.3).</p><p style="text-align:justify"><em><u>Pregnancy</u></em><br />No clinical data are available from women who became pregnant while taking solifenacin. Animal studies do not indicate direct harmful effects on fertility, embryonal / foetal development or parturition (see Section 5.3). The potential risk for humans is unknown. Caution should be exercised when prescribing to pregnant women.</p><p style="text-align:justify"><u><em>Breast-feeding</em></u><br />No data on the excretion of solifenacin in human milk are available. In mice, solifenacin and/or its metabolites was excreted in milk, and caused a dose dependent failure to thrive in neonatal mice (see Section 5.3). The use of Solfisan should therefore be avoided during breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Since solifenacin, like other anticholinergics may cause blurred vision, and, uncommonly, somnolence and fatigue (see section 4.8. undesirable effects), the ability to drive and use machines may be negatively affected.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Summary of the safety profile</u><br />Due to the pharmacological effect of solifenacin, Solfisan may cause anticholinergic undesirable effects of (in general) mild or moderate severity. The frequency of anticholinergic undesirable effects is dose related.</p><p style="text-align:justify">The most commonly reported adverse reaction with solifenacin was dry mouth. It occurred in 11% of patients treated with 5 mg once daily, in 22% of patients treated with 10 mg once daily and in 4% of placebo-treated patients. The severity of dry mouth was generally mild and did only occasionally lead to discontinuation of treatment. In general, medicinal product compliance was very high (approximately 99%) and approximately 90% of the patients treated with solifenacin completed the full study period of 12 weeks treatment.</p><p style="text-align:justify"><u>Tabulated list of adverse reactions</u></p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td style="text-align:justify"><strong>MedDRA<br />system<br />organ class</strong></td><td style="text-align:justify"><strong>Very<br />common<br />&ge;1/10</strong></td><td style="text-align:justify"><strong>Common<br />&ge;1/100,<br />&lt;1/10</strong></td><td style="text-align:justify"><strong>Uncommon<br />&ge;1/1000,</strong></td><td style="text-align:justify"><strong>Rare<br />&ge; 1/10000,<br />&lt;1/1000</strong></td><td style="text-align:justify"><strong>Very rare<br />&lt;1/10000</strong></td><td style="text-align:justify"><strong>Not known<br />(cannot be<br />estimated<br />from the<br />available<br />data)</strong></td></tr><tr><td style="text-align:justify">Infections<br />and<br />infestations</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Urinary tract infection,&nbsp;Cystitis</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td></tr><tr><td style="text-align:justify">Immune<br />system<br />disorder</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Anaphylactic<br />reaction*</td></tr><tr><td style="text-align:justify">Metabolism<br />and<br />nutrition<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Decreased appetite*<br />Hyperkalaemia*</td></tr><tr><td style="text-align:justify">Psychiatric<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Hallucinations*<br />Confusional<br />state*</td><td style="text-align:justify">Delirium*</td></tr><tr><td style="text-align:justify">Nervous<br />system<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Somnolence<br />Dysgeusia</td><td style="text-align:justify">Dizziness*,<br />Headache*</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td></tr><tr><td style="text-align:justify">Eye disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Blurred<br />vision</td><td style="text-align:justify">Dry eyes</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Glaucoma*</td></tr><tr><td style="text-align:justify">Cardiac<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Torsade de Pointes*<br />Electrocardiogram<br />QT prolonged*<br />Atrial fibrillation*<br />Palpitations*<br />Tachycardia</td></tr><tr><td style="text-align:justify">Respiratory, thoracic and mediastinal<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Nasal dryness</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Dysphonia*</td></tr><tr><td style="text-align:justify">Gastrointestinal<br />disorders</td><td style="text-align:justify">Dry mouth</td><td style="text-align:justify">Constipation<br />Nausea<br />Dyspepsia Abdominal<br />pain</td><td style="text-align:justify">Gastrooesophageal<br />reflux diseases<br />Dry throat</td><td style="text-align:justify">Colonic<br />obstruction<br />Faecal<br />impaction,<br />Vomiting*</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Ileus*<br />Abdominal discomfort*</td></tr><tr><td style="text-align:justify">Hepatobiliary<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Liver<br />disorder*&nbsp;Liver<br />function test<br />abnormal*</td></tr><tr><td style="text-align:justify">Skin and<br />subcutaneous<br />tissue<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Dry skin</td><td style="text-align:justify">Pruritus*<br />Rash*</td><td style="text-align:justify">Erythema<br />multiforme*<br />Urticaria*<br />Angioedema*</td><td style="text-align:justify">Exfoliative<br />dermatitis*</td></tr><tr><td style="text-align:justify">Musculoskeletal and<br />connective<br />tissue<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Muscular<br />weakness*</td></tr><tr><td style="text-align:justify">Renal and<br />urinary<br />disorders</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Difficulty in<br />micturition</td><td style="text-align:justify">Urinary<br />retention</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Renal<br />impairment*</td></tr><tr><td style="text-align:justify">General<br />disorders and<br />administration<br />site conditions</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Fatigue<br />Peripheral<br />oedema</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">&nbsp;</td></tr></tbody></table><p style="text-align:justify">*observed post-marketing</p><p style="text-align:justify"><u>Reporting of suspected adverse reactions</u><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.</p><p><strong>To report any side effect(s): </strong></p><ul><li><strong><em>Saudi Arabia:</em></strong><ul><li>The National Pharmacovigilance Centre (NPC)<ul><li><p>Fax: +966-11-205-7662</p></li><li><p>SFDA Call Center: 19999</p></li><li><p>E-mail: npc.drug@sfda.gov.sa</p></li><li><p>Website: https://ade.sfda.gov.sa</p></li></ul></li></ul></li><li><p><strong><em>Other GCC Slates:</em></strong></p></li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Symptoms</u><br />Overdosage with solifenacin succinate can potentially result in severe anticholinergic effects. The highest dose of solifenacin succinate accidentally given to a single patient was 280 mg in a 5 hour period, resulting in mental status changes not requiring hospitalization.</p><p style="text-align:justify"><u>Treatment</u><br />In the event of overdose with solifenacin succinate the patient should be treated with activated charcoal. Gastric lavage is useful if performed within 1 hour, but vomiting should not be induced.<br />As for other anticholinergics, symptoms can be treated as follows:</p><ul><li style="text-align:justify">Severe central anticholinergic effects such as hallucinations or pronounced excitation: treat with physostigmine or carbachol.</li><li style="text-align:justify">Convulsions or pronounced excitation: treat with benzodiazepines.</li><li style="text-align:justify">Respiratory insufficiency: treat with artificial respiration.</li><li style="text-align:justify">Tachycardia: treat with beta-blockers.</li><li style="text-align:justify">Urinary retention: treat with catheterisation.</li><li style="text-align:justify">Mydriasis: treat with pilocarpine eye drops and/or place patient in dark room.</li></ul><p style="text-align:justify">As with other antimuscarinics, in case of overdosing, specific attention should be paid to patients with known risk for QT-prolongation (i.e. hypokalaemia, bradycardia and concurrent administration of medicinal products known to prolong QT-interval) and relevant pre-existing cardiac diseases (i.e. myocardial ischaemia, arrhythmia, congestive heart failure).</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Pharmacotherapeutic group: Urinary antispasmodics, ATC code: G04B D08.</p><p style="text-align:justify"><u>Mechanism of action</u><br />Solifenacin is a competitive, specific cholinergic-receptor antagonist.<br />The urinary bladder is innervated by parasympathetic cholinergic nerves. Acetylcholine contracts the detrusor smooth muscle through muscarinic receptors of which the M3 subtype is predominantly involved. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor. In addition, solifenacin showed to be a specific antagonist for muscarinic receptors by displaying low or no affinity for various other receptors and ion channels tested.</p><p style="text-align:justify"><u>Pharmacodynamic effects</u><br />Treatment with solifenacin succinate in doses of 5 mg and 10 mg daily was studied in several double blind, randomised, controlled clinical trials in men and women with overactive bladder.<br />As shown in the table below, both the 5 mg and 10 mg doses of solifenacin succinate produced statistically significant improvements in the primary and secondary endpoints compared with placebo. Efficacy was observed within one week of starting treatment and stabilises over a period of 12 weeks. A long-term open label study demonstrated that efficacy was maintained for at least 12 months. After 12 weeks of treatment approximately 50% of patients suffering from incontinence before treatment were free of incontinence episodes, and in addition 35% of patients achieved a micturition frequency of less than 8 micturitions per day. Treatment of the symptoms of overactive bladder also results in a benefit on a number of Quality of Life measures, such as general health perception, incontinence impact, role limitations, physical limitations, social limitations, emotions, symptom severity, severity measures and sleep/energy.</p><p style="text-align:justify"><em>Results (pooled data) of four controlled Phase 3 studies with a treatment duration of 12 weeks</em></p><table border="1" cellspacing="1" cellpadding="1" style="width:586px"><tbody><tr><td style="text-align:justify">&nbsp;</td><td style="text-align:justify">Placebo</td><td style="text-align:justify; width:128px">Solifenacin 5 mg o.d.</td><td style="text-align:justify; width:104px">Solifenacin 10 mg</td><td style="text-align:justify; width:147px">Tolterodine 2 mg b.i.d.</td></tr><tr><td colspan="5" style="text-align:justify; width:583px"><strong>No. of micturitions/24 h</strong></td></tr><tr><td><p style="text-align:justify">Mean baseline</p><p style="text-align:justify">Mean reduction from baseline</p><p style="text-align:justify">% change from baseline</p><p style="text-align:justify">p-value*</p></td><td><p style="text-align:justify">11.9</p><p style="text-align:justify">1.4</p><p style="text-align:justify">(12%)</p><p style="text-align:justify">1138</p><p style="text-align:justify">&nbsp;</p></td><td style="width:128px"><p style="text-align:justify">12.1</p><p style="text-align:justify">2.3</p><p style="text-align:justify">(19%)</p><p style="text-align:justify">552</p><p style="text-align:justify">&lt;0.001</p></td><td style="width:104px"><p style="text-align:justify">11.9</p><p style="text-align:justify">2.7</p><p style="text-align:justify">(23%)</p><p style="text-align:justify">1158</p><p style="text-align:justify">&lt;0.001</p></td><td style="width:147px"><p style="text-align:justify">12.1</p><p style="text-align:justify">1.9</p><p style="text-align:justify">(16%)</p><p style="text-align:justify">250</p><p style="text-align:justify">0.004</p></td></tr><tr><td colspan="5" style="text-align:justify; width:583px"><strong>No. of urgency episodes/24 h</strong></td></tr><tr><td><p style="text-align:justify">Mean baseline</p><p style="text-align:justify">Mean reduction from baseline</p><p style="text-align:justify">% change from baseline</p><p style="text-align:justify">p-value*</p></td><td><p style="text-align:justify">6.3</p><p style="text-align:justify">2.0</p><p style="text-align:justify">(32%)</p><p style="text-align:justify">1124</p><p style="text-align:justify">&nbsp;</p></td><td style="width:128px"><p style="text-align:justify">5.9</p><p style="text-align:justify">2.9</p><p style="text-align:justify">(49%)</p><p style="text-align:justify">548</p><p style="text-align:justify">&lt;0.001</p></td><td style="width:104px"><p style="text-align:justify">6.2</p><p style="text-align:justify">3.4</p><p style="text-align:justify">(55%)</p><p style="text-align:justify">1151</p><p style="text-align:justify">&lt;0.001</p></td><td style="width:147px"><p style="text-align:justify">5.4</p><p style="text-align:justify">2.1</p><p style="text-align:justify">(39%)</p><p style="text-align:justify">250</p><p style="text-align:justify">0.031</p></td></tr><tr><td colspan="5" style="text-align:justify"><strong>No. of incontinence episodes/24 h</strong></td></tr><tr><td><p style="text-align:justify">Mean baseline</p><p style="text-align:justify">Mean reduction from baseline</p><p style="text-align:justify">% change from baseline</p><p style="text-align:justify">p-value*</p></td><td><p style="text-align:justify">2.9</p><p style="text-align:justify">1.1</p><p style="text-align:justify">(38%)</p><p style="text-align:justify">781</p><p style="text-align:justify">&nbsp;</p></td><td style="width:128px"><p style="text-align:justify">2.6</p><p style="text-align:justify">1.5</p><p style="text-align:justify">(58%)</p><p style="text-align:justify">314</p><p style="text-align:justify">0.001</p></td><td style="width:104px"><p style="text-align:justify">2.9</p><p style="text-align:justify">1.8</p><p style="text-align:justify">(62%)</p><p style="text-align:justify">778</p><p style="text-align:justify">0.001</p></td><td style="width:147px"><p style="text-align:justify">2.3</p><p style="text-align:justify">1.1</p><p style="text-align:justify">(48%)</p><p style="text-align:justify">157</p><p style="text-align:justify">0.009</p></td></tr><tr><td colspan="5" style="text-align:justify"><strong>No. of nocturia episodes/24 h</strong></td></tr><tr><td><p style="text-align:justify">Mean baseline</p><p style="text-align:justify">Mean reduction from baseline</p><p style="text-align:justify">% change from baseline</p><p style="text-align:justify">p-value*</p></td><td><p style="text-align:justify">1.8</p><p style="text-align:justify">0.4</p><p style="text-align:justify">(22%)</p><p style="text-align:justify">1005</p><p style="text-align:justify">&nbsp;</p></td><td style="width:128px"><p style="text-align:justify">2.0</p><p style="text-align:justify">0.6</p><p style="text-align:justify">(30%)</p><p style="text-align:justify">494</p><p style="text-align:justify">0.025</p></td><td style="width:104px"><p style="text-align:justify">1.8</p><p style="text-align:justify">0.6</p><p style="text-align:justify">(33%)</p><p style="text-align:justify">1035</p><p style="text-align:justify">0.001</p></td><td style="width:147px"><p style="text-align:justify">1.9</p><p style="text-align:justify">0.5</p><p style="text-align:justify">(26%)</p><p style="text-align:justify">232</p><p style="text-align:justify">0.119</p></td></tr><tr><td colspan="5" style="text-align:justify"><strong>Volume voided/micturition</strong></td></tr><tr><td><p style="text-align:justify">Mean baseline</p><p style="text-align:justify">Mean reduction from baseline</p><p style="text-align:justify">% change from baseline</p><p style="text-align:justify">p-value*</p></td><td><p style="text-align:justify">166ml</p><p style="text-align:justify">9ml</p><p style="text-align:justify">(5%)</p><p style="text-align:justify">1135</p><p style="text-align:justify">&nbsp;</p></td><td style="width:128px"><p style="text-align:justify">146ml</p><p style="text-align:justify">32ml</p><p style="text-align:justify">(21%)</p><p style="text-align:justify">552</p><p style="text-align:justify">0.001</p></td><td style="width:104px"><p style="text-align:justify">163ml</p><p style="text-align:justify">43ml</p><p style="text-align:justify">(26%)</p><p style="text-align:justify">1156</p><p style="text-align:justify">0.001</p></td><td style="width:147px"><p style="text-align:justify">147ml</p><p style="text-align:justify">24ml</p><p style="text-align:justify">(16%)</p><p style="text-align:justify">250</p><p style="text-align:justify">0.001</p></td></tr><tr><td colspan="5" style="text-align:justify"><strong>No. of pads/24 h</strong></td></tr><tr><td><p style="text-align:justify">Mean baseline</p><p style="text-align:justify">Mean reduction from baseline</p><p style="text-align:justify">% change from baseline</p><p style="text-align:justify">p-value*</p></td><td><p style="text-align:justify">3.0</p><p style="text-align:justify">0.8</p><p style="text-align:justify">(27%)</p><p style="text-align:justify">238</p><p style="text-align:justify">&nbsp;</p></td><td style="width:128px"><p style="text-align:justify">2.8</p><p style="text-align:justify">1.3</p><p style="text-align:justify">(46%)</p><p style="text-align:justify">236</p><p style="text-align:justify">0.001</p></td><td style="width:104px"><p style="text-align:justify">2.7</p><p style="text-align:justify">1.3</p><p style="text-align:justify">(48%)</p><p style="text-align:justify">242</p><p style="text-align:justify">0.001</p></td><td style="width:147px"><p style="text-align:justify">2.7</p><p style="text-align:justify">1.0</p><p style="text-align:justify">(37%)</p><p style="text-align:justify">250</p><p style="text-align:justify">0.010</p></td></tr></tbody></table><p style="text-align:justify"><u>Note:</u> In 4 of the pivotal studies, solifenacin succinate 10 mg and placebo were used. In 2 out of the 4 studies also solifenacin succinate 5 mg was used and one of the studies included tolterodine 2 mg bid.</p><p style="text-align:justify">Not all parameters and treatment groups were evaluated in each individual study. Therefore, the numbers of patients listed may deviate per parameter and treatment group.</p><p style="text-align:justify">* P-value for the pair wise comparison to placebo</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Absorption</u><br />After intake of solifenacin tablets, maximum solifenacin plasma concentrations (Cmax) are reached after 3 to 8 hours. The tmax is independent of the dose. The Cmax and area under the curve (AUC) increase in proportion to the dose between 5 to 40 mg. Absolute bioavailability is approximately 90%.<br />Food intake does not affect the Cmax and AUC of solifenacin.</p><p style="text-align:justify"><u>Distribution</u><br />The apparent volume of distribution of solifenacin following intravenous administration is about 600 L. Solifenacin is to a great extent (approximately 98%) bound to plasma proteins, primarily &alpha;1-acid glycoprotein.</p><p style="text-align:justify"><u>Biotransformation</u><br />Solifenacin is extensively metabolised by the liver, primarily by cytochrome P450 3A4 (CYP3A4). However, alternative metabolic pathways exist, that can contribute to the metabolism of solifenacin. The systemic clearance of solifenacin is about 9.5 L/h and the terminal half-life of solifenacin is 45 - 68 hours. After oral dosing, one pharmacologically active (4R-hydroxy solifenacin) and three inactive metabolites (Nglucuronide, N-oxide and 4R-hydroxy-N-oxide of solifenacin) have been identified in plasma in addition to solifenacin.</p><p style="text-align:justify"><u>Elimination</u><br />After a single administration of 10 mg [14C-labelled]-solifenacin, about 70% of the radioactivity was detected in urine and 23% in faeces over 26 days. In urine, approximately 11% of the radioactivity is recovered as unchanged active substance; about 18% as the N-oxide metabolite, 9% as the 4R-hydroxy-N-oxide metabolite and 8% as the 4Rhydroxy metabolite (active metabolite).</p><p style="text-align:justify"><u>Linearity/non-linearity</u><br />Pharmacokinetics are linear in the therapeutic dose range.</p><p style="text-align:justify"><u>Other special populations</u><br /><em>Elderly</em><br />No dosage adjustment based on patient age is required. Studies in elderly have shown that the exposure to solifenacin, expressed as the AUC, after administration of solifenacin succinate (5 mg and 10 mg once daily) was similar in healthy elderly subjects (aged 65 through 80 years) and healthy young subjects (aged less than 55 years). The mean rate of absorption expressed as tmax was slightly slower in the elderly and the terminal half-life was approximately 20% longer in elderly subjects. These modest differences were considered not clinically significant.<br />Pharmacokinetics of solifenacin have not been established in children and adolescents.</p><p style="text-align:justify"><em>Gender</em><br />Pharmacokinetics of solifenacin are not influenced by gender.</p><p style="text-align:justify"><em>Race</em><br />Pharmacokinetics of solifenacin are not influenced by race.</p><p style="text-align:justify"><em>Renal impairment</em><br />The AUC and Cmax of solifenacin in mild and moderate renally impaired patients, was not significantly different from that found in healthy volunteers. In patients with severe renal impairment (creatinine clearance &le; 30 ml/min) exposure to solifenacin was significantly greater than in the controls with increases in Cmax of about 30%, AUC of more than 100% and t&#39;12 of more than 60%. A statistically significant relationship was observed between creatinine clearance and solifenacin clearance.<br />Pharmacokinetics in patients undergoing haemodialysis have not been studied.</p><p style="text-align:justify"><em>Hepatic impairment</em><br />In patients with moderate hepatic impairment (Child-Pugh score of 7 to 9) the Cmax is not affected, AUC increased with 60% and t&#39;12 doubled. Pharmacokinetics of solifenacin in patients with severe hepatic impairment have not been studied.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, fertility, embryofetal development, genotoxicity, and carcinogenic potential. In the pre and postnatal development study in mice, solifenacin treatment of the mother during lactation caused dose-dependent lower postpartum survival rate, decreased pup weight and slower physical development at clinically relevant levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Tablet core</u><br />Lactose monohydrate<br />Maize starch<br />(Maize) starch, (partially) pregelatinised<br />Magnesium stearate<br />Water, purified</p><p><u>Coating&nbsp;5 mg:</u><br />Hypromellose 5cp<br />Titanium dioxide (E171)<br />Macrogol 8000<br />Talc<br />Iron oxide yellow (E172)<br />Water, purified</p><p><u>10 mg:</u><br />Hypromellose 5cp<br />Titanium dioxide (E171)<br />Macrogol 8000<br />Talc<br />Iron oxide red (E172)<br />Iron oxide yellow (E172)<br />Water, purified</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PVC/PE/PVDC/Aluminium blisters or Aluminium/Aluminium blisters<br />Pack of: 30 film-coated tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AJA Pharmaceutical Industries Company, Ltd.
Building no.6979, Hail Industrial City,
Hail 55414 Saudi Arabia
Tel: +966 11 268 7900
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>